The U.S. Secretary of Labor, state of California and a slew of healthcare groups are urging a federal appeals court to uphold a lower court's orders finding that a UnitedHealth Group Inc unit unreasonably denied mental health and substance abuse coverage and ordering it to reprocess 67,000 claims.
NCPA May 14, 2021
Dear Colleague,
Have you ever searched high and low for something (keys, cellphone, remotes come to mind) and you finally found it right in front of you? When that happens, someone invariably says, If it was a snake it would ve bit you.
I thought about that old phrase the other day as I pondered the discoveries being made about PBM business practices. The business practices for lack of a better word of PBMs are not new. Far from it. These discoveries are consistent with NCPA s objective of
changing the pharmacy payment model. NCPA has been shining a light on examples of PBM malfeasance for decades. Lately, we re seeing more and more PBM investigations across the country and there s a temptation to think, We ve been telling you this for years. Better late than never.
Share:
The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors.
Among the featured segments was one from Chris Capre on how to trade healthcare trends. Capre is the CEO and head trader of 2ndSkiesForex.
About Healthcare Trends: Healthcare is something everyone needs, which makes stocks in the sector a possible opportunity for investors. With the industry changing quickly, Capre shared his thoughts and offered some stock picks.
Capre told viewers that flow is king: It s important to look at flows for stock and at option flow, which suggests whether a stock might go up or down.
Liberty All-Star® Growth Fund, Inc April 2021 Monthly Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for developing countries reliant on the Chinese shot, which performed worse than western alternatives in clinical trials.